Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study. [electronic resource]
Producer: 20131126Description: 1675-9 p. digitalISSN:- 1468-2060
- Adalimumab
- Adolescent
- Adult
- Age Factors
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Psoriatic -- drug therapy
- Cohort Studies
- Disability Evaluation
- Etanercept
- Female
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- Male
- Middle Aged
- Pain Measurement -- methods
- Pensions -- statistics & numerical data
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Severity of Illness Index
- Sex Factors
- Sick Leave -- statistics & numerical data
- Sweden -- epidemiology
- Treatment Failure
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.